|Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay|
IG Bruno, R Karam, L Huang, A Bhardwaj, CH Lou, EY Shum, HW Song, ...
Molecular cell 42 (4), 500-510, 2011
|Evidence for an association of human papillomavirus and breast carcinomas|
APS Damin, R Karam, CG Zettler, M Caleffi, COP Alexandre
Breast cancer research and treatment 84 (2), 131-137, 2004
|Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer|
T Frebourg, C Oliveira, P Hochain, R Karam, S Manouvrier, C Graziadio, ...
Journal of medical genetics 43 (2), 138-142, 2006
|Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression|
C Oliveira, S Sousa, H Pinheiro, R Karam, R Bordeira–Carriço, J Senz, ...
Gastroenterology 136 (7), 2137-2148, 2009
|RNA homeostasis governed by cell type-specific and branched feedback loops acting on NMD|
L Huang, CH Lou, W Chan, EY Shum, A Shao, E Stone, R Karam, ...
Molecular cell 43 (6), 950-961, 2011
|Regulation of nonsense-mediated mRNA decay: implications for physiology and disease|
R Karam, J Wengrod, LB Gardner, MF Wilkinson
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1829 (6-7 …, 2013
|Posttranscriptional control of the stem cell and neurogenic programs by the nonsense-mediated RNA decay pathway|
CH Lou, A Shao, EY Shum, JL Espinoza, L Huang, R Karam, ...
Cell reports 6 (4), 748-764, 2014
|The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma|
C Liu, R Karam, YQ Zhou, F Su, Y Ji, G Li, GT Xu, LX Lu, CR Wang, ...
Nature medicine 20 (6), 596-598, 2014
|The unfolded protein response is shaped by the NMD pathway|
R Karam, CH Lou, H Kroeger, L Huang, JH Lin, MF Wilkinson
EMBO reports 16 (5), 599-609, 2015
|The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers|
R Karam, J Carvalho, I Bruno, C Graziadio, J Senz, D Huntsman, ...
Oncogene 27 (30), 4255-4260, 2008
|Gene‐specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel|
JL Mester, R Ghosh, T Pesaran, R Huether, R Karam, KS Hruska, ...
Human mutation 39 (11), 1581-1592, 2018
|Beyond DNA: an integrated and functional approach for classifying germline variants in breast cancer genes|
T Pesaran, R Karam, R Huether, S Li, S Farber-Katz, A Chamberlin, ...
International journal of breast cancer 2016, 2016
|Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants|
K Lee, K Krempely, ME Roberts, MJ Anderson, F Carneiro, E Chao, ...
Human mutation 39 (11), 1553-1568, 2018
|A conserved microRNA/NMD regulatory circuit controls gene expression|
R Karam, M Wilkinson
RNA biology 9 (1), 22-26, 2012
|Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect|
G Corso, J Figueiredo, C La Vecchia, P Veronesi, G Pravettoni, D Macis, ...
Journal of medical genetics 55 (7), 431-441, 2018
|Unexpected CDH1 Mutations Identified on Multigene Panels Pose Clinical Management Challenges|
K Lowstuter, CR Espenschied, D Sturgeon, C Ricker, R Karam, H LaDuca, ...
JCO Precision Oncology 1, 1-12, 2017
|Quantitative analysis of BRCA1 and BRCA2 germline splicing variants using a novel RNA-massively parallel sequencing assay|
S Farber-Katz, V Hsuan, S Wu, T Landrith, H Vuong, D Xu, B Li, J Hoo, ...
Frontiers in Oncology 8, 286, 2018
|Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria|
RM Xicola, S Li, N Rodriguez, P Reinecke, R Karam, V Speare, MH Black, ...
Journal of Medical Genetics 56 (12), 838-843, 2019
|Assessment of diagnostic outcomes of rna genetic testing for hereditary cancer|
R Karam, B Conner, H LaDuca, K McGoldrick, K Krempely, ...
JAMA network open 2 (10), e1913900-e1913900, 2019
DB CASTRO, M Ertel, RA Karam, R Bonfa, F Vargas, COP Alexandre
Porto Alegre, 2000